SCHEMBL18353752

SCHEMBL18353752

NC(=O)C1(Nc2cc(Cl)c(F)c(Cl)c2)CCN(Cc2ccccc2)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.58
ALDH1A1 P00352 2/20 0.58
NPFFR1 Q9GZQ6 9/20 0.52
NPFFR2 Q9Y5X5 9/20 0.52
OPRK1 P41145 4/20 0.52
OPRM1 P35372 2/20 0.52
OPRD1 P41143 1/20 0.52
TSHR P16473 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA5A P35218 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
CA14 Q9ULX7 1/20 0.47
MAPK1 P28482 1/20 0.43
NPY2R P49146 1/20 0.42
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16876704 0.90 CYP2D6 (0.59) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL16876688 0.89 ALDH1A1 (0.56) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL16876740 0.88 CYP2D6 (0.60) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL20187091 0.87 ALDH1A1 (0.56) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL2996293 0.85 CYP2D6 (0.68) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL5556286 0.85 ALDH1A1 (0.61) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL16876691 0.84 CYP2D6 (0.58) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL20187134 0.84 CYP2D6 (0.58) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL654357 0.83 ALDH1A1 (0.62) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1
SCHEMBL16876743 0.81 CYP2D6 (0.57) CYP2D6ALDH1A1NPFFR1NPFFR2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10428049-B2 TRPA1 modulators ALGOMEDIX, INC. (US) 2019-10-01 US disclosed
US-20190016701-A1 TRPA1 MODULATORS ALGOMEDIX, INC. (US) 2019-01-17 US disclosed
US-9951046-B2 TRPA1 modulators ALGOMEDIX, INC. (US) 2018-04-24 US disclosed
US-9951046-B2 TRPA1 modulators ALGOMEDIX, INC. (US) 2018-04-24 US disclosed
US-20170001983-A1 TRPA1 MODULATORS ALGOMEDIX, INC. 2017-01-05 US disclosed
US-20170001983-A1 TRPA1 MODULATORS ALGOMEDIX, INC. 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428049-B2 TRPA1 modulators TRPA1, TRPV1, TRPV2 CYP2D6 2163/4885ALDH1A1 1436/4885NPFFR1 270/4885
US-20170001983-A1 TRPA1 MODULATORS TRPA1, TRPV1, TRPV2 CYP2D6 2163/4885ALDH1A1 1436/4885NPFFR1 270/4885
US-20190016701-A1 TRPA1 MODULATORS TRPA1, TRPV1, TRPV2 CYP2D6 2163/4885ALDH1A1 1436/4885NPFFR1 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.